# Quagen Pharma, LLC – FDA Inspection, May 9, 2023

Source: https://www.keypedia.com/records/fda_inspections/quagen-pharma-llc/666fc434-9541-4099-b5b5-1371247a8209
Source feed: FDA_Inspections

> FDA inspection 1207909 of Quagen Pharma, LLC, May 09, 2023. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1207909
- Company Name: Quagen Pharma, LLC
- Inspection Date: 2023-05-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1306964 - 2026-04-17
- [FDA Inspection 1131910 - 2020-10-26](https://www.keypedia.com/records/fda_inspections/quagen-pharma-llc/37c76534-357b-4c19-a023-7470a89d61f6)
- [FDA Inspection 1082687 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/quagen-pharma-llc/1b77c1e2-436d-44c5-8066-9224307f23b0)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anthony-j-donato/a6dd6e14-529e-4b23-9b5f-02c88afb80ae)
- [JoshRenzo N. Ramilo](https://www.keypedia.com/people/joshrenzo-n-ramilo/c88227a7-0b4b-4526-9c56-97c38ab7bcea)

Company: https://www.keypedia.com/companies/quagen-pharma-llc/cd9437ab-54e0-430e-a568-3835f717bdf1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
